Ascendis Pharma (ASND) PT Raised to $190 at Oppenheimer
Tweet Send to a Friend
(Updated - September 17, 2024 6:52 AM EDT)
Oppenheimer analyst Leland Gershell raised the price target on Ascendis Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershell raised the price target on Ascendis Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
